895 results on '"Batista, Alzir A."'
Search Results
52. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors
53. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
54. Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis
55. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos -[(2-diphenylphosphino)phenyl]ether)
56. Nanoencapsulation of Ruthenium Complex Ru(ThySMet): A Strategy to Improve Selective Cytotoxicity Against Breast Tumor Cells in 2D and 3D Culture Models
57. Palladium(II)/N,N-disubstituted-N′-acylthioureas complexes as anti-Mycobacterium tuberculosis and anti-Trypanosoma cruzi agents
58. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
59. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
60. Heteroleptic tris-chelate ruthenium(II) complexes of N,N-disubstituted-N′-acylthioureas: Synthesis, structural studies, cytotoxic activity and confocal microscopy studies
61. Understanding the conformational changes and molecular structure of furoyl thioureas upon substitution
62. Hydroformylation-hydrogenation and hydroformylation-acetalization reactions catalyzed by ruthenium complexes
63. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF6[dppb = 1,4-bis(diphenylphosphine)butane and bipy = 2,2′-bipyridine]
64. Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
65. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
66. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis
67. Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer
68. Ruthenium(III)/phosphine/pyridine complexes applied in the hydrogenation reactions of polar and apolar double bonds
69. Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole
70. A ruthenium(II) complex with the propionate ion: Synthesis, characterization and cytotoxic activity
71. Cytotoxicity of Ru(II) piano–stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA
72. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells
73. Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling
74. Antimalarial Agents Derived from Metal‐Amodiaquine Complexes with Activity in Multiple Stages of the Plasmodium Life Cycle.
75. Copper(I)/Triphenylphosphine Complexes Containing Naphthoquinone Ligands as Potential Anticancer Agents.
76. New Copper(II)-L-Dipeptide-Bathophenanthroline Complexes as Potential Anticancer Agents—Synthesis, Characterization and Cytotoxicity Studies—And Comparative DNA-Binding Study of Related Phen Complexes
77. Cobalt(III)-py 2en Systems as Potential Carriers of β-Ketoester-Based Ligands
78. Ru(II)-based complexes with N-(acyl)-N′,N′-(disubstituted)thiourea ligands: Synthesis, characterization, BSA- and DNA-binding studies of new cytotoxic agents against lung and prostate tumour cells
79. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN = benzonitrile; N–N = 2,2′-bipyridine; 1,10-phenanthroline; P–P = 1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1′-(diphenylphosphino)ferrocene)
80. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
81. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
82. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
83. Human topoisomerase inhibition and DNA/BSA binding of Ru(II)–SCAR complexes as potential anticancer candidates for oral application
84. Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene
85. Dynamics of Formation of Binuclear Metal Complexes: A New Cu(I) Compound with N ‐(2‐thiophenecarbonyl)‐ N’ ‐(3‐Cl, 4‐F‐phenyl)thiourea as Ligand
86. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
87. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
88. Antiparasitic activities of novel ruthenium/lapachol complexes
89. On the cytotoxic activity of Pd(II) complexes of N,N-disubstituted-N′-acyl thioureas
90. Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents
91. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
92. Nitrosyl/Diphenylphosphine/Amino Acid–Ruthenium Complexes as Inhibitors of MDA-MB-231 Breast Cancer Cells.
93. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
94. N[sbnd]H⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
95. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
96. Synthesis of a ruthenium(II) tryptophan-associated complex and biological evaluation against Ehrlich murine breast carcinoma
97. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X = Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
98. Ruthenium(II) complexes with 2-(diphenylphosphinomethyl)aniline
99. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
100. Observation of vinylidene emission in mixed phosphine/diimine complexes of Ru(II) at room temperature in solution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.